Carbapenem Use in the Last Days of Life: A Nationwide Korean Study
暂无分享,去创建一个
Jieun Kim | Shinwon Lee | K. Kwon | S. Heo | Y. Yoon | Jian Hur | S. Kim | K. Sohn | Y. Wi | C. Moon | M. S. Lee | H. Cheong | Soyoon Hwang | Bongyoung Kim | Yoonjung Kim | Si-Ho Kim | Cheon-hoo Jeon | Sohyun Bae | Hyun-ha Chang | M. Lee | D. Jung | Antimicrobial Stewardship Research Committee Of Ko | Cheon-Hoo Jeon
[1] Jieun Kim,et al. Use of Antibiotics Within the Last 14 Days of Life in Korean Patients: A Nationwide Study , 2023, Journal of Korean medical science.
[2] Evangelos I. Kritsotakis,et al. A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. , 2023, The Journal of antimicrobial chemotherapy.
[3] A. Kwa,et al. Antibiotic stewardship program (ASP) in palliative care: antibiotics, to give or not to give , 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
[4] L. Jefferys,et al. Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit , 2020, Infection.
[5] J. Ruiz,et al. Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients , 2019, Antimicrobial Resistance & Infection Control.
[6] A. Boyer,et al. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case–case–control study , 2018, The Journal of antimicrobial chemotherapy.
[7] F. Barbier,et al. Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance? , 2018, International journal of antimicrobial agents.
[8] G. Raman,et al. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis , 2018, Antimicrobial Resistance & Infection Control.
[9] Herman Goossens,et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. , 2018, The Lancet. Global health.
[10] J. Gerber,et al. Physician Perceptions Regarding Antimicrobial Use in End-of-Life Care , 2018, Infection Control & Hospital Epidemiology.
[11] H. Higuchi,et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[12] L. Pyle,et al. A Handshake From Antimicrobial Stewardship Opens Doors for Infectious Disease Consultations , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] M. Bracken,et al. The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review , 2016, Open forum infectious diseases.
[14] E. S. Kim,et al. Frequent Prescription of Antibiotics and High Burden of Antibiotic Resistance among Deceased Patients in General Medical Wards of Acute Care Hospitals in Korea , 2016, PloS one.
[15] J. Robert,et al. Carbapenem use in French hospitals: A nationwide survey at the patient level. , 2015, International journal of antimicrobial agents.
[16] Tehmina S. Khan,et al. Impact of Infectious Diseases Team Consultation on Antimicrobial Use, Length of Stay and Mortality , 2015, The American journal of the medical sciences.
[17] F. Månsson,et al. An Audit-Based, Infectious Disease Specialist-Guided Antimicrobial Stewardship Program Profoundly Reduced Antibiotic Use Without Negatively Affecting Patient Outcomes , 2015, Open forum infectious diseases.
[18] J. Sohn,et al. Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship , 2014, PloS one.
[19] E. Lesaffre,et al. A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa , 2014, Antimicrobial Agents and Chemotherapy.
[20] M. Scheetz,et al. Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae , 2013, Antimicrobial Agents and Chemotherapy.
[21] D. Breilh,et al. Carbapenems , 2013, Journal of chemotherapy.
[22] F. Barbier,et al. Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients , 2013, Antimicrobial Agents and Chemotherapy.
[23] Jane M. Young,et al. Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.